BD PharmingenTM Purified Mouse anti-PLK1 (pT210)

Description

Western blot analysis of PLK1 pT210 in transformed human epithelioid carcinoma. Lysates from HeLa S3 cell line were probed with purified mouse anti-PLK1 pT210 monoclonal antibody at concentrations of 0.063, 0.032, and 0.016 mug/ml Lanes 1, 2, and 3, respectively with left panel or without right panel lambda protein phosphatase treatment. PLK1 pT210 is identified as a band of 68 kDa in the untreated cells. Western blot analysis of PLK1 pT210 in transformed human epithelioid carcinoma. Lysates from HeLa S3 cell line were probed with purified mouse anti-PLK1 pT210 monoclonal antibody at concentrations of 0.063, 0.032, and 0.016 mug/ml Lanes 1, 2, and 3, respectively with left panel or without right panel lambda protein phosphatase treatment. PLK1 pT210 is identified as a band of 68 kDa in the untreated cells. Show More Western blot analysis of PLK1 pT210 in transformed human epithelioid carcinoma. Lysates from HeLa S3 cell line were probed with purified mouse anti-PLK1 pT210 monoclonal antibody at concentrations of 0.063, 0.032, and 0.016 mug/ml Lanes 1, 2, and 3, respectively with left panel or without right panel lambda protein phosphatase treatment. PLK1 pT210 is identified as a band of 68 kDa in the untreated cells.